Mostrando 9 resultados de: 9
Filtros aplicados
Publisher
Current Pharmaceutical Design(2)
International Journal of Molecular Sciences(2)
Advances in Pharmacological Sciences(1)
Current Psychiatry Research and Reviews(1)
F1000Research(1)
Área temáticas
Enfermedades(8)
Fisiología humana(3)
Ginecología, obstetricia, pediatría, geriatría(1)
Medicina y salud(1)
Psicología aplicada(1)
Área de conocimiento
Bioquímica(2)
Enfermedad cardiovascular(2)
Farmacología(2)
Medicina interna(2)
Ciencia agraria(1)
Origen
scopus(9)
Chronobiology and chronotherapy in depression: Current knowledge and chronotherapeutic promises
ArticleAbstract: Background: Depression is a heavily prevalent mental disorder. Symptoms of depression extend beyondPalabras claves:Agomelatine, Chronobiology, Chronodisruption, Chronotherapy, Depression, SleepAutores:Batista M.J., Cano-Ponce C., Chávez-Castillo M., Díaz E.A., González M.C., Ortega A., Pírela D., Riaño M., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Valmore BermúdezFuentes:scopusDepression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines
ReviewAbstract: Depression is currently recognized as a crucial problem in everyday clinical practice, in light of ePalabras claves:Autores:Chávez-Castillo M., Nava M., Nuñez V., Ortega A., Rojas M., Rojas-Quintero J., Valmore BermúdezFuentes:scopusExploring phytotherapeutic alternatives for obesity, insulin resistance and diabetes mellitus
ReviewAbstract: At present, the pathologic spectrum of obesity-insulin resistance (IR)-diabetes mellitus (DM) repre-Palabras claves:Cardiovascular disease, diabetes mellitus, Insulin Resistance, Medicinal herbs, obesity, PhytotherapyAutores:Cano-Ponce C., Chávez-Castillo M., Durán P., González M.C., Marquina M., Nuñez V., Ortega A., Pírela D., Rojas M., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusNon-HDL cholesterol is better than ldl-c at pbkp_redicting atherosclerotic cardiovascular disease risk factors clustering, even in subjects with near-to-normal triglycerides: A report from a venezuelan population
ArticleAbstract: Background: Non-high density lipoprotein cholesterol (non-HDL-c) has emerged as an important tool inPalabras claves:ASCVD, cholesterol, Coronary artery disease, LDL-c, Non-HDL-c, risk factorAutores:de Bravo M.C., D’Addosio R., Graterol M., Graterol R., Hoedebecke K., Lameda V., Martínez M.S., Olivar L.C., Ortega A., Ramírez P., Rastogi S., Rojas E.R., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Torres W., Valmore Bermúdez, Wilches S.Fuentes:scopusMetabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches
ReviewAbstract: The constant changes in cancer cell bioenergetics are widely known as metabolic repro-gramming. ReprPalabras claves:Carbohydrates, Energy metabolism, immunotherapy, inflammation, Metabolic reprogramming, neoplasms, tumor microenvironmentAutores:de Sanctis J.B., Galbán N., Garrido B., González M.C., Navarro C., Ortega A., Santeliz R., Valmore Bermúdez, Vera I.Fuentes:scopusMetabolic risk in depression and treatment with selective serotonin reuptake inhibitors: are the metabolic syndrome and an increase in cardiovascular risk unavoidable?
ReviewAbstract: Depression is one of the most common psychiatric disorders, and has become an epidemic in modern medPalabras claves:Cardiovascular disease, Cardiovascular Risk, Chronic inflammation, Depression, Metabolic syndrome, Selective serotonin reuptake inhibitors, Type 2 Diabetes mellitusAutores:Chávez-Castillo M., Fuenmayor J., Lameda V., Nava M., Ortega A., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusPhytotherapy for cardiovascular disease: A bench-to-bedside approach
ReviewAbstract: At present, cardiovascular disease (CVD) remains the leading cause of morbidity and mortality world-Palabras claves:atherosclerosis, Cardiovascular disease, dyslipidemia, Hypertension, Medicinal herbs, PhytotherapyAutores:Cano-Ponce C., Chávez-Castillo M., Durán P., González M.C., Marquina M., Ortega A., Pírela D., Rojas-Quintero J., Salazar-Vílchez J., Valmore Bermúdez, Velasco M.Fuentes:scopusRole of endocrine-disrupting chemicals in the pathogenesis of non-alcoholic fatty liver disease: A comprehensive review
ReviewAbstract: Non-alcoholic fatty liver disease (NAFLD) is considered the most common liver disorder, affecting arPalabras claves:Endocrine-disrupting chemicals, Environmental pollutants, Exposure, Liver disorder, Non-alcoholic fatty liver diseaseAutores:Cano G., Cano R.A., Dávila L.C.A., Diaz M.P., Gomez Y., González M.C., Manzano A., Ortega A., Parra H., Pérez J.L., Rojas-Quintero J., Valero-Cedeño N.J., Valmore Bermúdez, Veliz T.Fuentes:scopusSpecialized pro-resolving lipid mediators: The future of chronic pain therapy?
ReviewAbstract: Chronic pain (CP) is a severe clinical entity with devastating physical and emotional con-sequencesPalabras claves:Central nervous system sensitization, Chronic pain, Eicosanoids, inflammation, Long-term poten-tiation, Nociception, Omega 3 fatty acids, pain management, Polyunsaturated fatty acids, Specialized pro-resolving lipid mediatorsAutores:Chávez-Castillo M., de Sanctis J.B., Durán P., Garrido B., Manzano A., Ortega A., Rojas M., Rojas-Gómez D.M., Salazar-Vílchez J., Silva A., Torres L.C., Valmore BermúdezFuentes:scopus